 | • レポートコード：QFJ1-3768 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、成人T細胞白血病/リンパ腫治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ブレンツキシマブベドチン、HBI-8000、その他）、用途別市場規模（病院、診療所、外来手術センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・成人T細胞白血病/リンパ腫治療の市場動向 ・企業の競争状況、市場シェア ・成人T細胞白血病/リンパ腫治療の種類別市場規模と予測2016-2027（ブレンツキシマブベドチン、HBI-8000、その他） ・成人T細胞白血病/リンパ腫治療の用途別市場規模と予測2016-2027（病院、診療所、外来手術センター、その他） ・成人T細胞白血病/リンパ腫治療の北米市場規模2016-2027（アメリカ、カナダ） ・成人T細胞白血病/リンパ腫治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・成人T細胞白血病/リンパ腫治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・成人T細胞白血病/リンパ腫治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・成人T細胞白血病/リンパ腫治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Daiichi Sankyo Co. Ltd.、Seattle Genetics Inc.、miRagen Therapeutics Inc.、Celgene Corporation (Bristol-Myers Squibb)、HUYA Bioscience International、Novartis、BioCryst Pharmaceuticals、Kyowa Kirin） ・結論 |
Market Analysis and Insights: Global Adult T-Cell Leukemia/Lymphoma Treatment Market
The global Adult T-Cell Leukemia/Lymphoma Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Adult T-Cell Leukemia/Lymphoma Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Adult T-Cell Leukemia/Lymphoma Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Adult T-Cell Leukemia/Lymphoma Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Adult T-Cell Leukemia/Lymphoma Treatment market.
Global Adult T-Cell Leukemia/Lymphoma Treatment Scope and Market Size
Adult T-Cell Leukemia/Lymphoma Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Adult T-Cell Leukemia/Lymphoma Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Brentuximab Vedotin
HBI-8000
Others
Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Daiichi Sankyo Co. Ltd.
Seattle Genetics Inc.
miRagen Therapeutics Inc.
Celgene Corporation (Bristol-Myers Squibb)
HUYA Bioscience International
Novartis
BioCryst Pharmaceuticals
Kyowa Kirin
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Adult T-Cell Leukemia/Lymphoma Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Brentuximab Vedotin
1.2.3 HBI-8000
1.2.4 Others
1.3 Market by Application
1.3.1 Global Adult T-Cell Leukemia/Lymphoma Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Adult T-Cell Leukemia/Lymphoma Treatment Market Perspective (2016-2027)
2.2 Adult T-Cell Leukemia/Lymphoma Treatment Growth Trends by Regions
2.2.1 Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Adult T-Cell Leukemia/Lymphoma Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Adult T-Cell Leukemia/Lymphoma Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Adult T-Cell Leukemia/Lymphoma Treatment Industry Dynamic
2.3.1 Adult T-Cell Leukemia/Lymphoma Treatment Market Trends
2.3.2 Adult T-Cell Leukemia/Lymphoma Treatment Market Drivers
2.3.3 Adult T-Cell Leukemia/Lymphoma Treatment Market Challenges
2.3.4 Adult T-Cell Leukemia/Lymphoma Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Adult T-Cell Leukemia/Lymphoma Treatment Players by Revenue
3.1.1 Global Top Adult T-Cell Leukemia/Lymphoma Treatment Players by Revenue (2016-2021)
3.1.2 Global Adult T-Cell Leukemia/Lymphoma Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Adult T-Cell Leukemia/Lymphoma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Adult T-Cell Leukemia/Lymphoma Treatment Revenue
3.4 Global Adult T-Cell Leukemia/Lymphoma Treatment Market Concentration Ratio
3.4.1 Global Adult T-Cell Leukemia/Lymphoma Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Adult T-Cell Leukemia/Lymphoma Treatment Revenue in 2020
3.5 Adult T-Cell Leukemia/Lymphoma Treatment Key Players Head office and Area Served
3.6 Key Players Adult T-Cell Leukemia/Lymphoma Treatment Product Solution and Service
3.7 Date of Enter into Adult T-Cell Leukemia/Lymphoma Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Adult T-Cell Leukemia/Lymphoma Treatment Breakdown Data by Type
4.1 Global Adult T-Cell Leukemia/Lymphoma Treatment Historic Market Size by Type (2016-2021)
4.2 Global Adult T-Cell Leukemia/Lymphoma Treatment Forecasted Market Size by Type (2022-2027)
5 Adult T-Cell Leukemia/Lymphoma Treatment Breakdown Data by Application
5.1 Global Adult T-Cell Leukemia/Lymphoma Treatment Historic Market Size by Application (2016-2021)
5.2 Global Adult T-Cell Leukemia/Lymphoma Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Adult T-Cell Leukemia/Lymphoma Treatment Market Size (2016-2027)
6.2 North America Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Type
6.2.1 North America Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Type (2016-2021)
6.2.2 North America Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Type (2022-2027)
6.2.3 North America Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Type (2016-2027)
6.3 North America Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Application
6.3.1 North America Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Application (2016-2021)
6.3.2 North America Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Application (2022-2027)
6.3.3 North America Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Application (2016-2027)
6.4 North America Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Country
6.4.1 North America Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Country (2016-2021)
6.4.2 North America Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Adult T-Cell Leukemia/Lymphoma Treatment Market Size (2016-2027)
7.2 Europe Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Type
7.2.1 Europe Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Type (2016-2021)
7.2.2 Europe Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Type (2022-2027)
7.2.3 Europe Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Type (2016-2027)
7.3 Europe Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Application
7.3.1 Europe Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Application (2016-2021)
7.3.2 Europe Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Application (2022-2027)
7.3.3 Europe Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Application (2016-2027)
7.4 Europe Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Country
7.4.1 Europe Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Country (2016-2021)
7.4.2 Europe Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Adult T-Cell Leukemia/Lymphoma Treatment Market Size (2016-2027)
8.2 Asia-Pacific Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Type
8.2.1 Asia-Pacific Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Application
8.3.1 Asia-Pacific Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Region
8.4.1 Asia-Pacific Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Adult T-Cell Leukemia/Lymphoma Treatment Market Size (2016-2027)
9.2 Latin America Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Type
9.2.1 Latin America Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Type (2016-2027)
9.3 Latin America Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Application
9.3.1 Latin America Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Application (2016-2027)
9.4 Latin America Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Country
9.4.1 Latin America Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Adult T-Cell Leukemia/Lymphoma Treatment Market Size (2016-2027)
10.2 Middle East & Africa Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Type
10.2.1 Middle East & Africa Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Application
10.3.1 Middle East & Africa Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Country
10.4.1 Middle East & Africa Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Daiichi Sankyo Co. Ltd.
11.1.1 Daiichi Sankyo Co. Ltd. Company Details
11.1.2 Daiichi Sankyo Co. Ltd. Business Overview
11.1.3 Daiichi Sankyo Co. Ltd. Adult T-Cell Leukemia/Lymphoma Treatment Introduction
11.1.4 Daiichi Sankyo Co. Ltd. Revenue in Adult T-Cell Leukemia/Lymphoma Treatment Business (2016-2021)
11.1.5 Daiichi Sankyo Co. Ltd. Recent Development
11.2 Seattle Genetics Inc.
11.2.1 Seattle Genetics Inc. Company Details
11.2.2 Seattle Genetics Inc. Business Overview
11.2.3 Seattle Genetics Inc. Adult T-Cell Leukemia/Lymphoma Treatment Introduction
11.2.4 Seattle Genetics Inc. Revenue in Adult T-Cell Leukemia/Lymphoma Treatment Business (2016-2021)
11.2.5 Seattle Genetics Inc. Recent Development
11.3 miRagen Therapeutics Inc.
11.3.1 miRagen Therapeutics Inc. Company Details
11.3.2 miRagen Therapeutics Inc. Business Overview
11.3.3 miRagen Therapeutics Inc. Adult T-Cell Leukemia/Lymphoma Treatment Introduction
11.3.4 miRagen Therapeutics Inc. Revenue in Adult T-Cell Leukemia/Lymphoma Treatment Business (2016-2021)
11.3.5 miRagen Therapeutics Inc. Recent Development
11.4 Celgene Corporation (Bristol-Myers Squibb)
11.4.1 Celgene Corporation (Bristol-Myers Squibb) Company Details
11.4.2 Celgene Corporation (Bristol-Myers Squibb) Business Overview
11.4.3 Celgene Corporation (Bristol-Myers Squibb) Adult T-Cell Leukemia/Lymphoma Treatment Introduction
11.4.4 Celgene Corporation (Bristol-Myers Squibb) Revenue in Adult T-Cell Leukemia/Lymphoma Treatment Business (2016-2021)
11.4.5 Celgene Corporation (Bristol-Myers Squibb) Recent Development
11.5 HUYA Bioscience International
11.5.1 HUYA Bioscience International Company Details
11.5.2 HUYA Bioscience International Business Overview
11.5.3 HUYA Bioscience International Adult T-Cell Leukemia/Lymphoma Treatment Introduction
11.5.4 HUYA Bioscience International Revenue in Adult T-Cell Leukemia/Lymphoma Treatment Business (2016-2021)
11.5.5 HUYA Bioscience International Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Adult T-Cell Leukemia/Lymphoma Treatment Introduction
11.6.4 Novartis Revenue in Adult T-Cell Leukemia/Lymphoma Treatment Business (2016-2021)
11.6.5 Novartis Recent Development
11.7 BioCryst Pharmaceuticals
11.7.1 BioCryst Pharmaceuticals Company Details
11.7.2 BioCryst Pharmaceuticals Business Overview
11.7.3 BioCryst Pharmaceuticals Adult T-Cell Leukemia/Lymphoma Treatment Introduction
11.7.4 BioCryst Pharmaceuticals Revenue in Adult T-Cell Leukemia/Lymphoma Treatment Business (2016-2021)
11.7.5 BioCryst Pharmaceuticals Recent Development
11.8 Kyowa Kirin
11.8.1 Kyowa Kirin Company Details
11.8.2 Kyowa Kirin Business Overview
11.8.3 Kyowa Kirin Adult T-Cell Leukemia/Lymphoma Treatment Introduction
11.8.4 Kyowa Kirin Revenue in Adult T-Cell Leukemia/Lymphoma Treatment Business (2016-2021)
11.8.5 Kyowa Kirin Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Adult T-Cell Leukemia/Lymphoma Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Brentuximab Vedotin
Table 3. Key Players of HBI-8000
Table 4. Key Players of Others
Table 5. Global Adult T-Cell Leukemia/Lymphoma Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Adult T-Cell Leukemia/Lymphoma Treatment Market Share by Regions (2016-2021)
Table 9. Global Adult T-Cell Leukemia/Lymphoma Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Adult T-Cell Leukemia/Lymphoma Treatment Market Share by Regions (2022-2027)
Table 11. Adult T-Cell Leukemia/Lymphoma Treatment Market Trends
Table 12. Adult T-Cell Leukemia/Lymphoma Treatment Market Drivers
Table 13. Adult T-Cell Leukemia/Lymphoma Treatment Market Challenges
Table 14. Adult T-Cell Leukemia/Lymphoma Treatment Market Restraints
Table 15. Global Adult T-Cell Leukemia/Lymphoma Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Adult T-Cell Leukemia/Lymphoma Treatment Market Share by Players (2016-2021)
Table 17. Global Top Adult T-Cell Leukemia/Lymphoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Adult T-Cell Leukemia/Lymphoma Treatment as of 2020)
Table 18. Ranking of Global Top Adult T-Cell Leukemia/Lymphoma Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Adult T-Cell Leukemia/Lymphoma Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Adult T-Cell Leukemia/Lymphoma Treatment Product Solution and Service
Table 22. Date of Enter into Adult T-Cell Leukemia/Lymphoma Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Adult T-Cell Leukemia/Lymphoma Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Adult T-Cell Leukemia/Lymphoma Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Adult T-Cell Leukemia/Lymphoma Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Adult T-Cell Leukemia/Lymphoma Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Adult T-Cell Leukemia/Lymphoma Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Adult T-Cell Leukemia/Lymphoma Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Adult T-Cell Leukemia/Lymphoma Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Daiichi Sankyo Co. Ltd. Company Details
Table 63. Daiichi Sankyo Co. Ltd. Business Overview
Table 64. Daiichi Sankyo Co. Ltd. Adult T-Cell Leukemia/Lymphoma Treatment Product
Table 65. Daiichi Sankyo Co. Ltd. Revenue in Adult T-Cell Leukemia/Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 66. Daiichi Sankyo Co. Ltd. Recent Development
Table 67. Seattle Genetics Inc. Company Details
Table 68. Seattle Genetics Inc. Business Overview
Table 69. Seattle Genetics Inc. Adult T-Cell Leukemia/Lymphoma Treatment Product
Table 70. Seattle Genetics Inc. Revenue in Adult T-Cell Leukemia/Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 71. Seattle Genetics Inc. Recent Development
Table 72. miRagen Therapeutics Inc. Company Details
Table 73. miRagen Therapeutics Inc. Business Overview
Table 74. miRagen Therapeutics Inc. Adult T-Cell Leukemia/Lymphoma Treatment Product
Table 75. miRagen Therapeutics Inc. Revenue in Adult T-Cell Leukemia/Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 76. miRagen Therapeutics Inc. Recent Development
Table 77. Celgene Corporation (Bristol-Myers Squibb) Company Details
Table 78. Celgene Corporation (Bristol-Myers Squibb) Business Overview
Table 79. Celgene Corporation (Bristol-Myers Squibb) Adult T-Cell Leukemia/Lymphoma Treatment Product
Table 80. Celgene Corporation (Bristol-Myers Squibb) Revenue in Adult T-Cell Leukemia/Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 81. Celgene Corporation (Bristol-Myers Squibb) Recent Development
Table 82. HUYA Bioscience International Company Details
Table 83. HUYA Bioscience International Business Overview
Table 84. HUYA Bioscience International Adult T-Cell Leukemia/Lymphoma Treatment Product
Table 85. HUYA Bioscience International Revenue in Adult T-Cell Leukemia/Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 86. HUYA Bioscience International Recent Development
Table 87. Novartis Company Details
Table 88. Novartis Business Overview
Table 89. Novartis Adult T-Cell Leukemia/Lymphoma Treatment Product
Table 90. Novartis Revenue in Adult T-Cell Leukemia/Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 91. Novartis Recent Development
Table 92. BioCryst Pharmaceuticals Company Details
Table 93. BioCryst Pharmaceuticals Business Overview
Table 94. BioCryst Pharmaceuticals Adult T-Cell Leukemia/Lymphoma Treatment Product
Table 95. BioCryst Pharmaceuticals Revenue in Adult T-Cell Leukemia/Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 96. BioCryst Pharmaceuticals Recent Development
Table 97. Kyowa Kirin Company Details
Table 98. Kyowa Kirin Business Overview
Table 99. Kyowa Kirin Revenue in Adult T-Cell Leukemia/Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 100. Kyowa Kirin Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Adult T-Cell Leukemia/Lymphoma Treatment Market Share by Type: 2020 VS 2027
Figure 2. Brentuximab Vedotin Features
Figure 3. HBI-8000 Features
Figure 4. Others Features
Figure 5. Global Adult T-Cell Leukemia/Lymphoma Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Ambulatory Surgical Centers Case Studies
Figure 9. Others Case Studies
Figure 10. Adult T-Cell Leukemia/Lymphoma Treatment Report Years Considered
Figure 11. Global Adult T-Cell Leukemia/Lymphoma Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Adult T-Cell Leukemia/Lymphoma Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Adult T-Cell Leukemia/Lymphoma Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Adult T-Cell Leukemia/Lymphoma Treatment Market Share by Regions (2022-2027)
Figure 15. Global Adult T-Cell Leukemia/Lymphoma Treatment Market Share by Players in 2020
Figure 16. Global Top Adult T-Cell Leukemia/Lymphoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Adult T-Cell Leukemia/Lymphoma Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Adult T-Cell Leukemia/Lymphoma Treatment Revenue in 2020
Figure 18. Global Adult T-Cell Leukemia/Lymphoma Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Adult T-Cell Leukemia/Lymphoma Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Adult T-Cell Leukemia/Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Adult T-Cell Leukemia/Lymphoma Treatment Market Share by Type (2016-2027)
Figure 22. North America Adult T-Cell Leukemia/Lymphoma Treatment Market Share by Application (2016-2027)
Figure 23. North America Adult T-Cell Leukemia/Lymphoma Treatment Market Share by Country (2016-2027)
Figure 24. United States Adult T-Cell Leukemia/Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Adult T-Cell Leukemia/Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Adult T-Cell Leukemia/Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Adult T-Cell Leukemia/Lymphoma Treatment Market Share by Type (2016-2027)
Figure 28. Europe Adult T-Cell Leukemia/Lymphoma Treatment Market Share by Application (2016-2027)
Figure 29. Europe Adult T-Cell Leukemia/Lymphoma Treatment Market Share by Country (2016-2027)
Figure 30. Germany Adult T-Cell Leukemia/Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Adult T-Cell Leukemia/Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Adult T-Cell Leukemia/Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Adult T-Cell Leukemia/Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Adult T-Cell Leukemia/Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Adult T-Cell Leukemia/Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Adult T-Cell Leukemia/Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Adult T-Cell Leukemia/Lymphoma Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Adult T-Cell Leukemia/Lymphoma Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Adult T-Cell Leukemia/Lymphoma Treatment Market Share by Region (2016-2027)
Figure 40. China Adult T-Cell Leukemia/Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Adult T-Cell Leukemia/Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Adult T-Cell Leukemia/Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Adult T-Cell Leukemia/Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Adult T-Cell Leukemia/Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Adult T-Cell Leukemia/Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Adult T-Cell Leukemia/Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Adult T-Cell Leukemia/Lymphoma Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Adult T-Cell Leukemia/Lymphoma Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Adult T-Cell Leukemia/Lymphoma Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Adult T-Cell Leukemia/Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Adult T-Cell Leukemia/Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Adult T-Cell Leukemia/Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Adult T-Cell Leukemia/Lymphoma Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Adult T-Cell Leukemia/Lymphoma Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Adult T-Cell Leukemia/Lymphoma Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Adult T-Cell Leukemia/Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Adult T-Cell Leukemia/Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Adult T-Cell Leukemia/Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Daiichi Sankyo Co. Ltd. Revenue Growth Rate in Adult T-Cell Leukemia/Lymphoma Treatment Business (2016-2021)
Figure 60. Seattle Genetics Inc. Revenue Growth Rate in Adult T-Cell Leukemia/Lymphoma Treatment Business (2016-2021)
Figure 61. miRagen Therapeutics Inc. Revenue Growth Rate in Adult T-Cell Leukemia/Lymphoma Treatment Business (2016-2021)
Figure 62. Celgene Corporation (Bristol-Myers Squibb) Revenue Growth Rate in Adult T-Cell Leukemia/Lymphoma Treatment Business (2016-2021)
Figure 63. HUYA Bioscience International Revenue Growth Rate in Adult T-Cell Leukemia/Lymphoma Treatment Business (2016-2021)
Figure 64. Novartis Revenue Growth Rate in Adult T-Cell Leukemia/Lymphoma Treatment Business (2016-2021)
Figure 65. BioCryst Pharmaceuticals Revenue Growth Rate in Adult T-Cell Leukemia/Lymphoma Treatment Business (2016-2021)
Figure 66. Kyowa Kirin Revenue Growth Rate in Adult T-Cell Leukemia/Lymphoma Treatment Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
世界の皮膚B細胞リンパ腫治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cutaneous B-Cell Lymphoma Treatment Market The global Cutaneous B-Cell Lymphoma Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and hig…- 世界のB細胞非ホジキンリンパ腫（NHL）治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market The global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy…
- 世界のT細胞急性リンパ芽球性白血病治療市場規模・現状・予測（2021年-2027年） T-cell acute lymphoblastic leukemia (T-ALL) is a type of acute lymphoblastic leukemia, with features similar to lymphoma. It affects white blood cells called T lymphocytes. Market Analysis and Insights: Global T-cell Acute Lymphoblastic Leukemia Treatment Market The global T-cell Acute Lymphoblastic…
- 世界の末梢T細胞リンパ腫（PTCL）治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Peripheral T-Cell Lymphoma (PTCL) Treatment Market The global Peripheral T-Cell Lymphoma (PTCL) Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in …
- 世界の皮膚T細胞リンパ腫（CTCL）治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cutaneous T-Cell Lymphoma (CTCL) Treatment Market The global Cutaneous T-Cell Lymphoma (CTCL) Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in an…